NIAID DMID research funding for infectious disease studies
2026 NIAID DMID Omnibus Broad Agency Announcement — Solicitation e33401d149fe42e9bf8ce366c9ca0f50, issued by Federal (Maryland place-of-performance).
In plain English
The National Institute of Allergy and Infectious Diseases (NIAID) awarded $23.9 million to Arisan Therapeutics for infectious disease research and development. This broad agency announcement funds scientific research and biomedical innovation in infectious disease modeling and diagnostics.
Key facts
- Issuing agency
- Federal (Maryland place-of-performance)
- Solicitation number
- e33401d149fe42e9bf8ce366c9ca0f50
- Type
- Award Notice
- Posted
- Aug 3, 2026
Award
Awarded to ARISAN THERAPEUTICS INC on Jul 29, 2026.
Full award intelligence — SledAtlas Pro
- Winning vendor's full award history — federal and Maryland local
- Recompete alert when this contract comes back around
- Award trends for this agency and category
Official description
Solicitation #HHS-NIH-NIAID-BAA2025-1. Issued by HEALTH AND HUMAN SERVICES, DEPARTMENT OF › NATIONAL INSTITUTES OF HEALTH › NATIONAL INSTITUTES OF HEALTH NIAID. NAICS 541715. Product/Service Code AN12. Awarded to ARISAN THERAPEUTICS INC for $23,878,987 on 2026-07-29.
Respond to this bid
This solicitation is administered by the issuing agency through its samgov procurement portal. Submission happens there, not on SledAtlas.
The direct link to the source posting is included with a free SledAtlas account — coming soon. Join the waitlist on the home page to get access at launch.